Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

NCT01060059 · clinicaltrials.gov ↗

COMPLETED

Status

888

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: exenatide
DRUG: basal insulin

Sponsor

AstraZeneca

Collaborators

[object Object]